Huzaifah Salat, Inaugural Regional Medical Director of Respiratory Care for Metro Milwaukee (Org 100) Hospitals, President Elect of Med Staff Leadership Council at Advocate Health, shared a post on LinkedIn:
“A lung doc walks into ASCO for the first time.
I expected cutting-edge science. What pleasantly surprised me was the conversation around AI, HCP engagement and thought leadership.
Physicians aren’t just using the fancy new tools; they’re questioning them. Asking the right questions about accuracy, bias, and real-world applicability. That kind of informed scrutiny doesn’t slow innovation down. It sharpens it. And it’s exactly what holds innovation accountable to the people who matter most: the ones at the bedside.
What gave me real optimism was seeing how that scrutiny is starting to close the gap between the bedside and the boardroom. Thought leadership forums built around genuine HCP engagement. Clinicians not just as end-users, but as architects of how these tools get built and deployed. The impact of that kind of collaboration is hard to overstate.
Bridging that gap isn’t just good for patients. It’s good for the industry.
Beyond the sessions, American Society of Clinical Oncology (ASCO) reminded me why showing up in person is irreplaceable. Virtual relationships became real ones. Conversations went deeper than any Zoom ever could.
Missed a few people in the 30h I was there; but hey that’s what next year is for.”
More posts featuring Huzaifah Salat.
